BrainVTA

BrainVTA is a global specialized service provider dedicated to supporting brain circuit research, disease research, gene therapy research and development through high-quality, reliable AAV vector construction and packaging solutions.

They offer end-to-end services, from vector design, screening, plasmid amplification to high-titer AAV packaging and comprehensive QC. Their core strength lies in their optimised, proprietary production platform, which ensures the delivery of high-quality products, accelerating your research timeline.

To date, they have supported over 200 pharmaceutical companies, 600 leading laboratories, and 3,000 researchers worldwide—contributing to more than 900 peer-reviewed publications. Their viral vector products and customised research services are widely applied in neuroscience, neurological disorders, gene and cell therapy, genetic disease modelling, oncology, and stem cell research. With proven reliability and strong scientific performance, BrainVTA is recognized as a trusted partner in advancing translational medicine.